The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia

Armin RashidiBone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Correspondence[email protected]

Ofir WolachDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;

Areej El-JawahriBone Marrow Transplant Unit, Massachusetts General Hospital, Boston, MA, USA

Vincent T. HoBone Marrow Transplant Unit, Massachusetts General Hospital, Boston, MA, USA

John F. DiPersioBone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA;

Robert SoifferBone Marrow Transplant Unit, Massachusetts General Hospital, Boston, MA, USA

Richard M. StoneDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;

Yi-Bin ChenBone Marrow Transplant Unit, Massachusetts General Hospital, Boston, MA, USA

show all

The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date